mesalamine and colchicine

mesalamine has been researched along with colchicine in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's3 (27.27)29.6817
2010's7 (63.64)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Crotty, B; Dalton, HR; Hoang, P; Jewell, DP1
Basturk, T; Kusaslan, R; Ozagari, A; Ozturk, T; Unsal, A1
Cheon, JH; Chung, MJ; Kim, NK; Kim, SU; Kim, TI; Kim, WH; Park, JJ1
Awaji, K; Inokuchi, R; Maehara, H; Moriyama, M; Ohmae, T; Okamoto, M; Suyama, Y1
Asano, T; Hashimoto, Y; Kawana, S; Kobayashi, H; Matsuoka, N; Migita, K; Sato, S; Tasaki, K; Watanabe, H; Yashiro, M1
Chiang, BL; Hu, YC; Lee, JH; Lin, YT; Wang, LC; Yang, YH; Yu, HH1

Reviews

2 review(s) available for mesalamine and colchicine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
    Journal of renal care, 2009, Volume: 35, Issue:3

    Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colchicine; Crohn Disease; Disease Progression; Early Diagnosis; Humans; Hypertension; Hypoalbuminemia; Kidney Failure, Chronic; Male; Mesalamine; Proteinuria; Rare Diseases; Renal Dialysis; Risk Factors; Time Factors

2009

Other Studies

9 other study(ies) available for mesalamine and colchicine

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression.
    Gut, 1992, Volume: 33, Issue:1

    Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cell Line; Colchicine; Colon; Epithelium; Flow Cytometry; HLA-DR Antigens; Humans; Inflammatory Bowel Diseases; Interferon-gamma; Male; Mesalamine; Middle Aged; Salicylates

1992
Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease.
    Journal of clinical gastroenterology, 2010, Volume: 44, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Colchicine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intestinal Diseases; Korea; Male; Mesalamine; Middle Aged; Prognosis; Recurrence; Risk Factors; Time Factors; Treatment Outcome; Ulcer; Young Adult

2010
Gastrointestinal Behçet's disease: periodic fever, multiple ulcers and trisomy 8 in elderly man.
    QJM : monthly journal of the Association of Physicians, 2018, Aug-01, Volume: 111, Issue:8

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Capsule Endoscopy; Chromosomes, Human, Pair 8; Colchicine; Gastrointestinal Diseases; Gout Suppressants; Humans; Male; Mesalamine; Treatment Outcome; Trisomy; Ulcer

2018
Behçet disease associated with gastrointestinal amyloidosis manifested as hematochezia: A case report.
    Medicine, 2018, Volume: 97, Issue:26

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Colchicine; Colon; Colonic Diseases; Gastrointestinal Hemorrhage; Glucocorticoids; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Mesalamine; Middle Aged; Prednisolone; Tubulin Modulators; Ulcer

2018
Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
    BMC pediatrics, 2019, 07-11, Volume: 19, Issue:1

    Topics: Adalimumab; Adolescent; Antirheumatic Agents; Behcet Syndrome; Child; Colchicine; Drug Therapy, Combination; Etanercept; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Mesalamine; Prednisolone; Retrospective Studies; Severity of Illness Index; Sulfasalazine; Symptom Assessment; Taiwan; Tertiary Care Centers; Treatment Outcome; Tumor Necrosis Factor-alpha

2019